Workflow
Milestone Scientific(MLSS)
icon
Search documents
Milestone Scientific(MLSS) - 2019 Q2 - Quarterly Report
2019-08-14 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of ...
Milestone Scientific(MLSS) - 2019 Q1 - Quarterly Report
2019-05-14 20:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of ...
Milestone Scientific(MLSS) - 2018 Q4 - Earnings Call Transcript
2019-04-04 00:13
Milestone Scientific Inc (NYSE:MLSS) Q4 2018 Earnings Conference Call April 3, 2019 8:30 AM ET Company Participants David Waldman - Investor Relations Leonard Osser - Interim Chief Executive Officer Joseph D???Agostino - Chief Financial Officer and Chief Operating Officer Conference Call Participants Alexander Scharf - Maxim Group Anthony Marchese - Private Investor Les Collins - Private Investor Tony Kamin - Eastwood Partners Ricky Solomon - Private Investor Operator Good day and welcome to the Milestone S ...
Milestone Scientific(MLSS) - 2018 Q4 - Annual Report
2019-04-01 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Common Stock, par value $.001 per share NYSE A ...